Cellectar Biosciences
- Pharmaceutical Preparations
- Florham Park, New Jersey
Compensation history
Top executives at Cellectar Biosciences received an average of $639K per person in annual compensation from 2013 to 2023.
By year
Executives
We found 14 executives who work or worked at Cellectar Biosciences.
James Caruso
Cellectar Biosciences
Chief Executive Officer
Jarrod Longcor
Cellectar Biosciences
Chief Operating Officer
Chad Kolean
Cellectar Biosciences
Chief Financial Officer
John Friend
Cellectar Biosciences
Chief Medical Officer
Dov Elefant
Cellectar Biosciences
Chief Financial Officer
Igor Grachev
Cellectar Biosciences
Chief Medical Officer
Charles Bernhardt
Cellectar Biosciences
Chief Financial Officer
Brian Posner
Cellectar Biosciences
Chief Financial Officer
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019
About Cellectar Biosciences
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 100 Campus Drive, Florham Park, New Jersey 07932
- (608) 441-8120
- December 31
- Former names
- NOVELOS THERAPEUTICS, INC.
- COMMON HORIZONS INC